Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA
- PMID: 2155379
- DOI: 10.1007/BF00220716
Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA
Abstract
Both thymidine kinase (TK) and DNA polymerase (DNAp) are present in measurable amounts in human serum. Even though the use of TK as a clinical marker is rapidly increasing there has been no attempt to characterize the serum TK in a wider extent, i.e.; with respect to Mw or other biochemical parameters. Therefore sera with high TK or DNAp activities derived from patients with cytomegalovirus (CMV) infection, B12-deficiency and leukaemia were fractionated by gel exclusion chromatography. The TK activity eluted as two peaks, one major TK activity with an apparent molecular weight (Mw) or 730 kD and one minor TK activity corresponding to a Mw of 58 kD. The amount of TK activity at 58 kD varied between 7 and 23% of total activity, depending on the serum fractionated. The DNAp activity in sera from patients with malignant disease and B12 deficiency eluted as a single peak corresponding to a Mw of 240 kD. A DNAp with a different Mw (greater than 1000 kD) was recovered from 1 of 3 investigated immunosuppressed patients with CMV infection. A similar pattern of enzyme forms was observed when sera were separated by glycerol gradient centrifugation. The effect of high salt and various reaction solution components on the enzymes were studied. The only condition found that affected the molecular forms of TK was the state of reduction. Incubation of sera with high concentrations of dithioerythritol (DTE) (400 mM) prior to separation transferred all serum TK to the 58 kD form, it also converted most of the serum DNAp from the 240 kD form to a smaller form (56 kD) without affecting the total recovery of enzymatic activity. The reaction product from both TK forms was exclusively monophosphate and none of the TK forms could efficiently utilize cytidine triphosphate as phosphate donor. The substrate kinetics of the small serum TK fraction was identical with those of an enzyme with similar size purified from proliferating HeLa cells, indicating that both serum TK activities are forms of TK 1, the proliferation associated cellular isozyme.
Similar articles
-
Improved assays for DNA-polymerizing enzymes by the use of enzymatically synthesized 5-[125I]iodo-2'-deoxyuridine triphosphate, illustrated by direct quantitation of anti-HIV reverse transcriptase antibody and by serum DNA polymerase analyses.Biotechnol Appl Biochem. 1990 Feb;12(1):34-56. Biotechnol Appl Biochem. 1990. PMID: 1690011
-
Chimeric polypeptide of thymidine kinase and thymidylate kinase of shrimp white spot syndrome virus: thymidine kinase activity of the recombinant protein expressed in a baculovirus/insect cell system.Virology. 2002 Aug 1;299(2):248-55. doi: 10.1006/viro.2002.1480. Virology. 2002. PMID: 12202227
-
Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.J Virol. 2000 Jan;74(2):684-92. doi: 10.1128/jvi.74.2.684-692.2000. J Virol. 2000. PMID: 10623730 Free PMC article.
-
[Thymidine kinase activities in sera and liver tissues during hepatocarcinogenesis in rats treated with 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB)].Nihon Gan Chiryo Gakkai Shi. 1990 Dec 20;25(12):2794-801. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2074389 Japanese.
-
Enzymatic channeling of DNA precursors.Basic Life Sci. 1985;31:47-66. doi: 10.1007/978-1-4613-2449-2_4. Basic Life Sci. 1985. PMID: 2986590 Review. No abstract available.
Cited by
-
Preferent Diaphragmatic Involvement in TK2 Deficiency: An Autopsy Case Study.Int J Mol Sci. 2021 May 25;22(11):5598. doi: 10.3390/ijms22115598. Int J Mol Sci. 2021. PMID: 34070501 Free PMC article.
-
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.BMC Cancer. 2015 Feb 18;15:66. doi: 10.1186/s12885-015-1073-8. BMC Cancer. 2015. PMID: 25881026 Free PMC article.
-
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.BMC Vet Res. 2014 Oct 8;10:228. doi: 10.1186/s12917-014-0228-1. BMC Vet Res. 2014. PMID: 25293656 Free PMC article.
-
Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer.Cancers (Basel). 2021 Oct 29;13(21):5442. doi: 10.3390/cancers13215442. Cancers (Basel). 2021. PMID: 34771604 Free PMC article.
-
Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.BMC Biochem. 2012 Jun 28;13:12. doi: 10.1186/1471-2091-13-12. BMC Biochem. 2012. PMID: 22741536 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources